Description
TNF-α (Adalimumab Biosimilar) Human mAb was confirmed to bind to its intended target protein TNF-α using bio-layer interferometry. TNF-α (Adalimumab Biosimilar) Human mAb is produced at Cell Signaling Technology. Adalimumab is an antibody directed against TNF-α.
Target
TNF-alpha
Target Alias Names
TNF, TNF-a
Isotype/Mimetic
IgG1 kappa
Animal-Derived Biomaterials Used
BSA
Sequence Available
Yes
Original Discovery Method
Immunization
Antibody/Binder Origins
Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation